Tysabri

News

Polpharma in pole position for biosimilar Tysabri in Europe

Polpharma Biologics has become the first company to file for approval in the EU of a biosimilar version of Biogen's blockbuster multiple sclerosis therapy

News

Pills spilling out of a prescription bottle on 100 dollar paper currency

AbbVie's Humira tops ICER's list of unwarranted price hikes ...

With drug pricing controls back on the legislative table in the US, the influential Institute for Clinical and Economic Review (ICER) has published its third report on "unsupported" price i

News

Closeup of X-ray photography of human brain

Tysabri failure in stroke a setback for Biogen

Biogen’s hopes that one of its established multiple sclerosis drugs might also help stroke sufferers have been dashed.

Polpharma in pole position for biosimilar Tysabri in Europe

AbbVie's Humira tops ICER's list of unwarranted price hikes ...

Tysabri failure in stroke a setback for Biogen

Pulmonary fibrosis drug developer Avalyn files IPO

Using AI-driven synthetic personas to take your insights fur...

Editor's Picks